Raab & Moskowitz Asset Management LLC Roivant Sciences Ltd. Transaction History
Raab & Moskowitz Asset Management LLC
- $413 Million
- Q2 2025
A detailed history of Raab & Moskowitz Asset Management LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Raab & Moskowitz Asset Management LLC holds 11,000 shares of ROIV stock, worth $219,889. This represents 0.03% of its overall portfolio holdings.
Number of Shares
11,000
Previous 11,000
-0.0%
Holding current value
$219,889
Previous $110,000
11.82%
% of portfolio
0.03%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
364Shares Held
456MCall Options Held
8.36MPut Options Held
760K-
Sb Investment Advisers (Uk) LTD London, X060MShares$1.2 Billion5.36% of portfolio
-
Morgan Stanley New York, NY44.7MShares$893 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$786 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$707 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$684 Million1.22% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $14.1B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...